Orion Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Orion Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$78.8K	Sell	1,300 -250	-16%	-$14.6K	0.03%	217
2025 Q4	$83.6K	Hold	1,550	–	–	0.03%	222
2025 Q3	$69.9K	Hold	1,550	–	–	0.02%	239
2025 Q2	$71.8K	Hold	1,550	–	–	0.03%	209
2025 Q1	$94.5K	Hold	1,550	–	–	0.04%	180
2024 Q4	$87.7K	Buy	+1,550	New	+$86.6K	0.04%	182
2024 Q3	–	Sell	-1,550	Closed	-$64.4K	–	181
2024 Q2	$64.4K	Sell	1,550 -1,000	-39%	-$44.7K	0.03%	197
2024 Q1	$138K	Hold	2,550	–	–	0.07%	142
2023 Q4	$131K	Hold	2,550	–	–	0.08%	147
2023 Q3	$148K	Buy	+2,550	New	+$156K	0.1%	136
2023 Q2	–	Sell	-2,700	Closed	-$187K	–	183
2023 Q1	$187K	Buy	2,700 +250	+10%	+$17.6K	0.13%	119
2022 Q4	$176K	Hold	2,450	–	–	0.13%	118
2022 Q3	$174K	Hold	2,450	–	–	0.14%	109
2022 Q2	$189K	Buy	2,450 +1,000	+69%	+$76.2K	0.15%	103
2022 Q1	$106K	Hold	1,450	–	–	0.06%	164
2021 Q4	$90K	Buy	1,450 +1,000	+222%	+$58.7K	0.05%	170
2021 Q3	$27K	Hold	450	–	–	0.02%	230
2021 Q2	$30K	Hold	450	–	–	0.02%	205
2021 Q1	$28K	Hold	450	–	–	0.02%	199
2020 Q4	$28K	Buy	+450	New	+$27.7K	0.02%	192

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Orion Capital Management's BMY Position: Q1 2026 in Review

Orion Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 16% in Q1 2026, selling an estimated $14.6K and leaving 1,300 shares worth $78.8K. The position accounts for 0.03% of the portfolio, ranked #217.

Orion Capital Management first reported a position in BMY in Q4 2020 and has held it in 20 quarters since. The position peaked at $189K in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Orion Capital Management held 1,300 shares of Bristol-Myers Squibb worth $78.8K as of Q1 2026.
Orion Capital Management sold 250 Bristol-Myers Squibb shares in Q1 2026, an estimated $14.6K.
Bristol-Myers Squibb made up 0.03% of Orion Capital Management's portfolio in Q1 2026, its #217 holding.
Orion Capital Management first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 20 quarters since.
Orion Capital Management's Bristol-Myers Squibb position peaked at $189K in Q2 2022.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Orion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.